Filing Details

Accession Number:
0001209191-20-000391
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-02 17:16:44
Reporting Period:
2019-12-30
Accepted Time:
2020-01-02 17:16:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566373 Spring Bank Pharmaceuticals Inc. SBPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1424591 M Kurt Eichler C/O Spring Bank Pharmaceuticals, Inc.
35 Parkwood Drive
Hopkinton MA 01748
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-30 40,000 $1.26 549,273 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,791 Indirect See footnote
Common Stock 10,000 Indirect See footnote
Common Stock 1,200 Indirect See footnote
Footnotes
  1. These shares are directly held by Theresa Eichler as custodian for Katherine Eichler UGMA NJ. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.
  2. These shares are directly held by the Kurt M. Eichler Trust Under Agreement dated 12/27/14 FBO Katherine Eichler (the "Katherine Eichler Trust"). The Reporting Person's immediate family member, Katherine Eichler, is a beneficiary of the Katherine Eichler Trust, and the Reporting Person is a trustee of the Katherine Eichler Trust.
  3. These shares are directly held by the Reporting Person as custodian for Katherine Eichler. Katherine Eichler is an immediate family member sharing a household with the Reporting Person.